Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Equine Diseases
Equine diseases encompass a wide range of health conditions that can affect horses, including infectious diseases, metabolic disorders, and genetic conditions. These diseases can impact the overall health, performance, and well-being of horses. Common equine diseases include equine influenza, equine herpesvirus, laminitis, and equine metabolic syndrome. Diagnosis and management of these diseases often require a combination of clinical evaluation, laboratory testing, and appropriate treatment strategies. This page gathers peer-reviewed research studies and scholarly articles that explore the etiology, pathophysiology, diagnosis, and treatment options for various equine diseases, providing valuable insights for veterinarians and researchers in the field.
[Effectiveness of coumaphos against chorioptes bovis in a horse with foot-mange (author’s transl)]. A horse with foot-mange failed to recover following a number of courses of treatment with coumaphos. Mites isolated from this horse were tested in vitro for their sensitivity to coumaphos and lindane. The mites were resistant to coumaphos and sensitive to lindane. Following treatment with lindane, the horse recovered within four weeks.
Serological response in mares affected by contagious equine metritis 1977. A serum agglutination and antiglobulin test is described for the detection of antibodies to the contagious equine metritis organism. A provisional interpretation of the test is proposed and using this interpretation the results of 66 such tests are discussed.
Survival of 59Fe-labeled erythrocytes in cross-transfused equine blood. Whole blood containing 59Fe-labeled erythrocytes (RBC) and unlabeled serum was transfused from a donor horse on 2 occasions into each of 6 recipient horses. Survival of transfused cells was monitored in the recipients as a function of time after transfusion by measuring RBC radioactivity in the recipients. After the 1st transfusion, RBC concentration of 59Fe remained at 60% to 100% of the transfused dose for 4 days, after which radioactivity values dropped to less than 10% of the dose by 6 days in 3 horses. In the 3 other horses, RBC radioactivity dropped immediately after transfusion, reachin...
Neurologic signs and neuropathology associated with a case of equine infectious anemia. Neurologic signs and neuropathologic lesions associated with a case of equine infectious anemia in a 7 year old Quarter-horse mare were studied. Clinical signs included depression, disorientation, circling, knuckling at the fetlock and hypermetria. The neuropathologic lesions were characterized by a granulomatous ependymitis, subependymal encephalitis, choroiditis and hydrocephalus. These lesions were associated with signs of neurologic dysfunction which were the cause of the prominent clinical features.
Metastatic phycomycosis in a horse. Extensive subcutaneous phycomycosis of the lower hindlimb developed over a period of 8 months in a Thoroughbred filly. There was no response to treatments such as trichlorphon, sodium iodide, or etisazole. Extension of the limb lesion over the following 3 months was associated with an enlarged inguinal lymph node, which was removed. Characteristic phycomycotic lesions were observed in the node, and a fungus having the morphologic features of Hyphomyces destruens was isolated from both the limb and nodal lesions.
Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Twenty-nine horses were vaccinated with a trivalent (Venezuelan, eastern, and western) inactivated equine encephalomyelitis virus vaccine. The vaccine purchased for this study was the only one licensed and commercially available in May, 1975. Plaque-neutralizing and hemagglutinin-inhibiting antibodies in response to each of the 3 equine encephalomyelitis viruses were determined after vaccination. Horses had rising levels of plaque-neutralizing and hemagglutinin-inhibiting antibodies shortly after injection with the 1st and 2nd doses of the vaccine (given 3 weeks apart) and were refractory to c...
Ameloblastic ondontoma in a foal. A 4 month old foal with right sided maxillary enlargement and considerable upper airway obstruction had an ameloblastic odontoma in the right maxillary sinus. This odontogenic tumour, probably congenital in nature, had extensively distorted the structure and contours of the sinus, and displaced the adjacent turbinates and nasal septum.
Induction of a cell membrane antigen by equine infectious anemia virus. Equine fibroblasts persistently infected with equine infectious anemia virus acquire a new cell membrane antigen demonstrable by indirect radioimmunoassay, using infected horse serum as an antibody source.
Surgical implications of extensibility of the skin of the equine carpus. To determine the lines of maximum extensibility of the skin over the equine carpus, round puncture wounds were made 2.0 cm apart over the carpal area of 5 horses (7 carpi). The direction of elongation of the round puncture wound was observed and photographed. Lines of maximum extensibility that occurred over the surfaces of the equine carpus were determined to be proximal to distal, except in a small area over the accessory carpal bone where a state of anisotropism existed. In an immobilized carpus, direction of a surgical incision was not as important as it was in a mobile carpus, in which th...
Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Of 359 horses vaccinated with attenuated Venezuelan equine encephalomyelitis (VEE) vaccine (strain TC-83), 87% developed hemagglutination-inhibition (HI) antibodies to VEE virus within 1 month. Blood from a subsample of 101 of the 359 horses was obtained over a 1-year period. Within 1 month after vaccination, 84% of the 101 horses had developed VEE HI antibodies, 87% had developed VEE-neutralizing (Nt) antibodies, and 78% had developed VEE complement-fixing (CF) antibodies. One year after vaccination, 58% of the horses had VEE HI antibodies and 73% had VEE Nt antibodies. The percentage of hors...
